Cognitive Impairment Clinical Trial
Official title:
Examining the Effectiveness of Action-based Cognitive Remediation for First Episode Psychosis
Verified date | January 2020 |
Source | University of Manitoba |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cognitive impairments are a core and enduring feature of first-episode psychosis and
schizophrenia, and are associated with significant functional impairment. Cognitive
remediation (CR) is a behavioural intervention that has been found to have a small to
moderate effect on cognition in individuals with schizophrenia, and recent studies suggests
that it leads to improved cognition in persons with first-episode psychosis. Results from a
CR feasibility project that was conducted through the Winnipeg Regional Health Authority's
Early Psychosis Prevention and Intervention Service (EPPIS) showed promising findings.
Specifically, large effect sizes were found in the areas of verbal learning and self-esteem.
Moreover, the intervention was found to be acceptable to the participants. However, the
findings are limited by the sample size and lack of control group.
In this proposed study, the investigators seek to expand the scientific support for treating
neurocognitive impairments in order to increase functional productivity associated with
first-episode psychosis. A novel group CR program, action-based cognitive remediation (ABCR),
has been developed by Dr. C. Bowie (co-investigator) to promote the generalization of
cognitive skills to real-world activities. ABCR has been found to improve both cognition and
functional competence in persons with schizophrenia. The primary outcome measure will examine
whether ABCR results in improved executive functioning in persons with first-episode
psychosis compared to psychiatric rehabilitation alone. Secondary outcome measures (e.g.,
memory, processing speed, self-esteem, emotional functioning, adaptive functioning) will also
be analyzed.
Status | Completed |
Enrollment | 13 |
Est. completion date | November 30, 2019 |
Est. primary completion date | June 14, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 37 Years |
Eligibility |
Inclusion Criteria: - Involved in the Winnipeg Regional Health Authority's Early Psychosis Prevention and Intervention Service - Must be at least 18 years old - Be proficient in English - Have stable medication orders for 3 months - Have capacity to voluntarily consent to participate in the treatment study Exclusion Criteria: - Organic brain damage - Intellectual disability |
Country | Name | City | State |
---|---|---|---|
Canada | Crisis Response Centre | Winnipeg | Manitoba |
Lead Sponsor | Collaborator |
---|---|
University of Manitoba | Queen's University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Executive Functioning; Wisconsin Card Sorting Test (Heaton and PAR Staff, 2005). | Commonly used neuropsychological computerized test to assess the ability to form abstract concepts, to shift and maintain set, and to utilize feedback. Total number of categories completed and perseverative errors (reported as t-score with range <20 to >80) will be reported. Higher values indicate better outcome. More information can be found at: http://www4.parinc.com/Products/Product.aspx?ProductID=WCST | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Cognitive Functioning; Screen for Cognitive Impairment in Psychiatry (Purdon, 2005). | Scale for screening cognitive deficits in persons with schizophrenia and psychiatry, including verbal learning and memory, auditory working memory, verbal fluency and visuomotor tracking. Total score reported as a z-score (range of -3 to +3). Higher values indicate better performance. | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Psychotic Symptoms; Brief Psychotic Rating Scale (Overall & Gorham, 1962). | A 24-item measure commonly used in research and clinical settings that is designed to quantify the severity of positive and negative symptoms of psychosis. Scale ranges from 24-168. Higher values indicate greater number and severity of symptoms. | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Functional Skills; Canadian Objective Life Skills (COALS) (McDermid Vaz & Heinrichs) | Participants are examined with a series of role-playing tasks for their comprehension and planning of recreational activities, financial skills in handling money and writing checks, use of a telephone for instrumental communication, and ability to use information from bus schedules and maps to use public transportation effectively. Total score ranges from 0-60. Higher value indicates better performance. | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Visual Memory; Brief visuospatial memory test-revised (Benedict, 1997). | Commonly-used neuropsychological measure of visual learning and memory that uses a multiple-figural test to assess immediate memory, delayed memory and recognition abilities. Recall scores are reported as t-scores (range: <20-80) and higher values indicate better performance. Please note that a copy of the test protocol cannot be provided due to copyright protection, but more information can be found at: http://www4.parinc.com/Products/Product.aspx?ProductID=BVMT. | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Self-Esteem; Rosenberg Self-Esteem Scale (Rosenberg, 1965). | A 10-item measure that is commonly used to measure self-esteem. Respondents are asked to read a list of statements dealing with general feelings about themselves and rate each one on a four-point scale from SD =Strongly Disagree (score of 0) to SA =Strongly Agree (score of 3). Scores are summed to provide a total score for the measure. Total score ranges from 0-30, with higher values indicating higher self-esteem. | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Disability Beliefs; World Health Organization Disability Assessment Schedule II (World Health Organization) | 36-item self-administered measure that assesses disability in adults over 18 years. Total score ranges from 0-144 with higher scores indicating greater perceived disability. | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Illness Beliefs; Personal Beliefs About Illness Questionnaire-Revised (Birchwood, Jackson, Brunet, Holden & Barton, 2012). | 20-item, self-report measure that assesses common psychological reactions related to loss, social marginalization, shame, entrapment, and control in persons with a first-episode psychosis. Total score ranges from 0-60. Higher scores indicate negative reactions to the diagnosis. | Baseline, after approximately 8 weeks and 16 weeks | |
Secondary | Change in Perceived Competence; Perceived Competence for Learning Scale | 4-item self-report measure assessing person's feeling of competence to master learning material. Total score ranges from 4-28. Higher scores indicate greater perceived competence. | Baseline, after approximately 8 weeks and 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Recruiting |
NCT04356924 -
Psychological Treatment to Support the Consequences of Cognitive Impairment
|
N/A | |
Suspended |
NCT05542238 -
The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
|
N/A | |
Terminated |
NCT04493957 -
Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT04426838 -
Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
|
N/A | |
Completed |
NCT04713384 -
Remote Bimanual Virtual Rehabilitation Post CVD
|
N/A | |
Recruiting |
NCT06284213 -
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
|
||
Recruiting |
NCT06053775 -
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)
|
N/A | |
Completed |
NCT03698695 -
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05552729 -
Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT03187353 -
IMProving Executive Function Study
|
Phase 4 | |
Completed |
NCT03301402 -
Air Purifier to Improve Endothelial Function and Carotid Intima Thickness
|
N/A | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Recruiting |
NCT05030285 -
Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment
|
N/A | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Recruiting |
NCT04907565 -
Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
|